What the Alzheimer's drug approval in the U.S. could mean for Canada
The U.S. FDA approved North America’s first Alzheimer’s treatment Lecanemab, also known as Leqembi. What does that mean for Canadians living with the disease?
The U.S. FDA approved North America’s first Alzheimer’s treatment Lecanemab, also known as Leqembi. What does that mean for Canadians living with the disease?